Advertisement
Screener

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) Net Income (Loss) Available to Common Stockholders, Basic

2.4 / 5 stars · 24/50 Roast Me

BIOFORCE NANOSCIENCES HOLDINGS, INC. Net Income (Loss) Available to Common Stockholders, Basic

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported Net Income (Loss) Available to Common Stockholders, Basic of $238.68 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-10

  • BIOFORCE NANOSCIENCES HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was $238.68K.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$102.41K.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$115.92K.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$122.78K.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 month
2026-06-30$238.68K
10-Q · filed 2026-08-10
$136.27K
derived: sum of 2 quarters · filed 2026-08-10
2026-03-31-$102.41K
10-Q · filed 2026-08-10
2025-09-30-$115.92K
10-Q · filed 2025-11-19
-$238.70K
derived: sum of 2 quarters · filed 2026-08-10
-$1.17M
derived: sum of 3 quarters · filed 2026-08-10
2025-06-30-$122.78K
10-Q · filed 2026-08-10
-$1.06M
derived: sum of 2 quarters · filed 2026-08-10
2025-03-31-$934.65K
10-Q · filed 2026-08-10
2024-09-30-$122.02K
10-Q · filed 2025-11-19
-$236.46K
derived: sum of 2 quarters · filed 2025-11-19
-$367.28K
derived: sum of 3 quarters · filed 2025-11-19
2024-06-30-$114.44K
10-Q · filed 2025-11-19
-$245.25K
derived: sum of 2 quarters · filed 2025-11-19
2024-03-31-$130.81K
10-Q · filed 2025-11-19